Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06294119 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Multivariate Approach to the Numerical Assessment of Cortical - Autonomic - VAscular Dynamic Interplay

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Notable Trial status: Not Yet Recruiting to Recruiting Primary and study completion dates: Feb 28, 2026 to Feb 28, 2029 · Start date changed from estimate of May 8, 2025 to Sep 30, 2025 · Site details revisedv3 Show 3 more changesShow less
    • Primary and study completion dates: Feb 28, 2026 to Feb 28, 2029
    • Start date changed from estimate of May 8, 2025 to Sep 30, 2025
    • Site details revised
  2. Notable Start date: Feb 8, 2024 to May 8, 2025 Trial status: Recruiting to Not Yet Recruiting · Primary and study completion dates: Feb 8, 2026 to Feb 28, 2026 · Site details revisedv2 Show 3 more changesShow less
    • Trial status: Recruiting to Not Yet Recruiting
    • Primary and study completion dates: Feb 8, 2026 to Feb 28, 2026
    • Site details revised
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
MANCAVA sets out fundamental methodologies for characterizing human fundamental physiological system interactions at a whole-body level, particularly focusing on the interplay among cortical brain activity, autonomic function, and cerebrovascular autoregulatory mechanisms. By investigating the complex, time-varying mechanisms underlying the multisystem dynamic interactions, novel methods linking various brain areas and reflex functions to target organs and districts such as heart and circulatory system are proposed with the clinical aim linked to the emerging topic of depression. In this scenario, proper new mathematical tools will allow a significant leap from the current state of the art, paving the way towards a new understanding of leading comorbid contributors to global diseases such as cardiac and cerebrovascular morbidity in mood disorders. In turn, this will provide an integration among physiological and psychological dimensions for a more holistic view on depression. Researchers, professionals, and patients will all benefit from a comprehensive assessment of brain-mind-body interplay, leading to the new extended definition of default mode/mood network, neurovascular-evoked responses to autonomic stimuli, brain-autonomic consequences of emotional responses, and physiological substrates of depressive states.
Trial Details
NCT Number NCT06294119
Lead Sponsor IRCCS Policlinico S. Donato
Conditions Cardiac Disease, Depression
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov